Diagnostic accuracy of saliva-based testing as a Vibrio cholerae surveillance tool among naturally infected patients
Clinical and Experimental Immunology · 2025
DOI: 10.1093/cei/uxae092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2025. Verfasst von Caroline C Chisenga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Enteric Disease and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia. Hauptthemen laut MEDLINE: Saliva, Cholera, Vibrio cholerae, Antibodies, Bacterial. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, NIAID NIH HHS, Bacterial Vaccines Network.
Abstract (Originalsprache)
Saliva, as a diagnostic medium, offers a promising alternative to blood by virtue of its non-invasive collection, which enhances patient compliance, especially in paediatric and geriatric populations. In this study, we assessed the utility of saliva as a non-invasive medium for measuring Vibrio cholerae-specific serum antibodies in naturally infected individuals. We tested paired serum and saliva samples obtained from a total of 63 patients with cholera enrolled in a cohort study. Vibriocidal antibodies assay (IgM/IgG) as markers for accurate determination was used to determine cholera-specific antibody levels. Using receiver operating characteristics (ROC) curve, we found that the best cut-off that maximizes (sensitivity + specificity) is 10 titres. At this saliva titre, the sensitivity is 76.9% (95%CI: 60.9%, 87.7%) and specificity is 80.0% (95%CI: 56.6%, 92.5%). Using Spearman’s correlation coefficient, we also found evidence of a positive correlation between V. cholerae saliva and serum antibodies (rho = 0.66, P < 0.001). In conclusion, saliva-based diagnostic cholera tests have high diagnostic accuracy and would be advantageous, cheaper, and quicker for early diagnosis of severe cholera outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Enteric Disease and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
- Alter Lab, Ragon Institute of MGH, MIT and Harvard, Boston, USA.
- Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, UK.
- Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
- Department of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana.
ORCID-Profile: Caroline C Chisenga
Förderung
- Medical Research Council
- NIAID NIH HHS
- Bacterial Vaccines Network
Zitieren
APA
Chisenga, C. C., Phiri, B., Ng'ombe, H., Muchimba, M., Liswaniso, F., Bernshtein, B., Cunningham, A. F., Sack, D., & Bosomprah, S. (2025). Diagnostic accuracy of saliva-based testing as a Vibrio cholerae surveillance tool among naturally infected patients. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxae092
Vancouver
Chisenga CC, Phiri B, Ng'ombe H, Muchimba M, Liswaniso F, Bernshtein B, et al. Diagnostic accuracy of saliva-based testing as a Vibrio cholerae surveillance tool among naturally infected patients. Clinical and Experimental Immunology. 2025. doi:10.1093/cei/uxae092
BibTeX
@article{Chisenga2025,
author = {Chisenga, Caroline C and Phiri, Bernard and Ng'ombe, Harriet and Muchimba, Mutinta and Liswaniso, Fraser and Bernshtein, Biana and Cunningham, Adam F and Sack, David and Bosomprah, Samuel},
title = {Diagnostic accuracy of saliva-based testing as a Vibrio cholerae surveillance tool among naturally infected patients},
journal = {Clinical and Experimental Immunology},
year = {2025},
doi = {10.1093/cei/uxae092}
}
EUVIMED